Refine by
Cancer Detection Articles & Analysis
186 news found
It opens the door to a deeper understanding of inflammatory pathways and the diverse roles neutrophils play in chronic diseases, autoimmunity, and cancer. By improving the ability to detect and monitor these cells, researchers are creating opportunities for more precise diagnostic tools and innovative therapeutic strategies. ...
The portfolio features both a tumor-naïve assay and a tumor-informed assay that are designed to help detect residual disease or early cancer recurrence and monitor for immunotherapy treatment response, providing valuable insights to inform patient management strategies. ...
ByTempus
Recently, the product manager of the company was pleased to announce the launch of its Cancer Cytokines Assay, assisting in the detection of multiple cytokine levels within a single sample. The cocktail of cytokines produced in the cancer microenvironment has important roles in cancer pathogenesis. Cytokines released during ...
“We are focused on building out our portfolio of assays for early cancer detection and treatment management while maintaining our commitment to continual improvement of our products,” stated Rashid Bux, CEO of BioMark. ...
The miR Sentinel™ Prostate Cancer Test is a standalone, non-invasive liquid biopsy urine test that can, from a single urine specimen, accurately detect molecular evidence of prostate cancer and, if cancer is detected, classify the severity, or the risk grade, of the malignancy. The proprietary ...
The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most challenging research process. Cancer is known to cause by the accumulation of harmful genetic mutations within cells. ...
“Breast cancer is the most common cancer worldwide, impacting millions of women and their loved ones around the world,” said Dr. Julia Camps Herrero, Corporate Chief of Breast Health, Ribera Salud Hospitals Spain. “Early detection of cancer can save lives. Imaging options such as contrast-enhanced mammography ...
ByBayer AG
The technology is also designed to potentially enhance colorectal cancer screenings. Its powerful, proprietary artificial intelligence and computer vision technologies have the potential to improve the accuracy and consistency of endoscopy readings. Iterative Scopes is initially applying these advances to impact polyp detection for colorectal ...
(“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce several updates from ongoing clinical trial using the Company’s liquid biopsy test for early cancer detection and ...
NextPoint’s programs aim to deliver monotherapies for cancer patients without viable treatment options. While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. Similar to PD-L1, the tumor antigen HHLA2 is a member of the B7 ...
ByBayer AG
Abstract title: “Metabolomic Profiling for the Early Detection of Lung Cancer”. The results demonstrated the high accuracy of BioMark’s quantitative metabolomic platform to identify early-stage lung cancer in retrospective plasma samples from individual with smoking history compared to participants suffering from other lung ...
(“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today the publication of a preclinical study demonstrating therapeutic capabilities of its SAT1 cancer marker in glioblastoma (GB) cells using an ionizable lipid ...
It is a special time to gather with loved ones and check-in to make sure everyone is happy and healthy. November is also lung cancer awareness month. VisionGate wants to help you, your family and loved ones learn more about who is at risk, the impact, and the types of lung cancer. Because keeping yourself informed about the risks and early ...
He doesn’t think FRI will affect disease detection or classification; these activities have now been done for over 100 years visually on radiographic images. ...
ByFluidda
Nanostics is currently in the process of launching a simple blood test called ClarityDX Prostate® that can aid in the detection of clinically significant prostate cancer, as the group’s research has shown that using ClarityDX Prostate® as a reflex test vs. the PSA test alone could have resulted in 37 per cent fewer unnecessary biopsies. ...
(USA), a leading Liquid Biopsy company, is pleased to announce that National Institute of Integrative Medicine’s (Melbourne, Australia) researchers obtained striking results in a group of Australian men using the ISET® test for early prostate cancer diagnosis through the detection of Prostate-Specific Antigen (PSA) positive Circulating Tumor Cells ...
Its pipeline of products includes two mono-cancer tests designed for early detection of Prostate Cancer and Acute Myeloid Leukemia, and an early detection multi-cancer test to identify any of multiple cancers in a subject from a simple blood draw. “Our team has a groundbreaking approach to ...
Rarecells, Inc., a healthcare company in the field of liquid biopsy, focused on the development and commercialization of non-invasive tests for early cancer detection, announced today that it has entered into an agreement with Columbia University to fund a clinical study evaluating its ISET -AML test for early detection of acute myeloid leukemia ...
ScreenPoint Medical's, VP of US Sales, Nicki Bryan, said 2021 has been the year when using AI to find breast cancers faster and earlier has been universally accepted as a vital tool in the battle to improve survival rates. "We have proven that AI is a vital tool for early detection of breast cancer, particularly at a time when screening backlogs ...
Food and Drug Administration (FDA) for adults undergoing colorectal cancer screening or surveillance. SKOUT, a real-time computer-aided polyp detection device developed by Iterative Scopes, uses advanced computer vision technology designed to recognize suspicious tissue and provide real-time feedback to gastroenterologists. ...